Lymphoma, mantle cell
Clinical trials for Lymphoma, mantle cell explained in plain language.
Never miss a new study
Get alerted when new Lymphoma, mantle cell trials appear
Sign up with your email to follow new studies for Lymphoma, mantle cell, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called LY4152199 in about 215 adults with certain types of blood cancer (like follicular lymphoma or diffuse large B-cell lymphoma) that have already been treated. The drug is designed to help the body's immune cells attack the cancer. The …
Matched conditions: LYMPHOMA, MANTLE CELL
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Promising drug cocktail takes on tough lymphoma
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—glofitamab, venetoclax, and zanubrutinib—in people with high-risk mantle cell lymphoma, either newly diagnosed or after relapse. The study will enroll 100 participants across three groups based on their treatment history.…
Matched conditions: LYMPHOMA, MANTLE CELL
Phase 2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC